InsidersTradesSigma
Follow the Syngene International Limited stock price and the full directors' dealings record of the company, a listed equity based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Syngene International Limited has logged 364 reports. Market capitalisation: €160.7bn. The latest transaction was disclosed on 27 December 2024 (Sale). Among the most active insiders: ALOK MEHROTRA. All data is openly available.
364
Insider Decl.
n/a
Thresholds
€29m
95 ops.
Buy Volume
€508m
267 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Syngene International Limited Buy (bullish), based on 8 analysts. Average price target: ₹559.38.
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,601 of 29,064 companies
56.8
score / 100
Value43
Quality71
FCF yld3.4%
Earn yld2.0%
EV/EBITDA18.2x
ROE6.6%
Gross mgn75%
Net mgn8.8%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 December 2024
Declarations364 total
6,190 shares@ ₹850.593.4% of flowEquity SharesSEBI:28f32d90f272bc48e1acd0c103f332b315149b50
27,200 shares@ ₹843.5415.0% of flowEquity SharesSEBI:07b59d7cbaf7e5df0b1622138efe6a04752c8dcc
58,390 shares@ ₹859.7332.9% of flowEquity SharesSEBI:150ddcc74ef4d9ad91a4ed8805a8c951acca6556
8,000,000 shares@ ₹857.6815.9% of flowEquity SharesSEBI:57e4123aae4c2c8bd0756ffebeb2b288705b2536
600 shares@ ₹889.3516.8% of flowEquity SharesSEBI:1fffd8cb3ac46d89ae50730020a666caeed48dd2
600 shares@ ₹907.1517.3% of flowEquity SharesSEBI:d779a34d9eeacacd898d60923fa109e203497a8c
1,500 shares@ ₹913.1731.4% of flowEquity SharesSEBI:1521b816c33918933d9e133aa466cb70e626c117
8,200 shares@ ₹858.225.1% of flowEquity SharesSEBI:52cc72390db10c7178555297839d940341e2e766
20,000 shares@ ₹876.0312.6% of flowEquity SharesSEBI:f41d3b0b55768570c70a2924441adad80b16c8ea
35,000 shares@ ₹913.648.8% of flowEquity SharesSEBI:b31bc8310cb179c9401e132dcf0a639ca17eac27
86,431 shares@ ₹889.9321.1% of flowEquity SharesSEBI:7efa8fcd912c6b25f9fdfc553cee345d982d82a9
2,394 shares@ ₹873.59982.7% of flowEquity SharesSEBI:fa07d3858e629c008bf217a11fc9dce1781434d8
2,587 shares@ ₹880.002.5% of flowEquity SharesSEBI:db562ede74e7d46192ce8ca9b61041836e21ce3d
2,500 shares@ ₹872.002.4% of flowEquity SharesSEBI:8928d04a1aa26994b22662247bbdc230f25e9600
5,000 shares@ ₹845.004.6% of flowEquity SharesSEBI:c3600f30be65c285c4b5c158a874d481a124fc8b
500 shares@ ₹857.080.3% of flowEquity SharesSEBI:fc0dc44b543c2714a82b2ec1189dea7577b080b6
1,000 shares@ ₹853.990.6% of flowEquity SharesSEBI:56ea5e1ea4dd6b106767491bc07ce72de9810e6c
5,000 shares@ ₹846.886.7% of flowEquity SharesSEBI:d2a0342a5a0570bcf40156637dbc28879818c073
6,400 shares@ ₹850.508.0% of flowEquity SharesSEBI:b36447e9ff1030b4b09ae463ddf61b7fd58e4458
7,100 shares@ ₹840.997.7% of flowEquity SharesSEBI:69c2ff203a36d8d2d081d9aced6a80de9e4d0756
5,600 shares@ ₹840.994.8% of flowEquity SharesSEBI:b312cd8abb8929f668aab9da434e41e9bdbb5de9
17,287 shares@ ₹832.2018.5% of flowEquity SharesSEBI:6923e7f4cf31accd1495f221339f43ffeaf70140
21,626 shares@ ₹832.2018.2% of flowEquity SharesSEBI:3f06898b3727afd7328a7f9675e80625aa56bdf6
25 of 364 declarations
关于 Syngene International Limited
Syngene International Limited 是一家专注于生物制药解决方案研发的公司。该公司为制药和生物技术公司提供合同研究服务。